Kobe, Japan

Hidekazu Imahori

This inventor holds 1 USPTO granted patent. Top assignee: Knc Laboratories Co., Ltd.. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hidekazu Imahori. Retrieved from https://idiyas.com/inventor/hidekazu-imahori

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Hidekazu Imahori

Introduction

Hidekazu Imahori is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of chemistry, particularly in the synthesis of vitamin D derivatives. His innovative approach utilizes cost-effective materials, showcasing his commitment to advancing scientific research.

Latest Patents

Imahori holds a patent for "Intermediates for synthesis of vitamin D derivatives." This invention provides a novel intermediate for synthesizing vitamin D derivatives by using a less expensive material. The compound is synthesized using carvone as a starting material, represented by specific chemical formulae.

Career Highlights

Imahori is associated with Knc Laboratories Co., Ltd., where he continues to contribute to research and development. His work emphasizes the importance of innovation in the pharmaceutical industry, particularly in creating more accessible methods for synthesizing essential compounds.

Collaborations

Some of his notable coworkers include Hiroya Koyama and Daisuke Yoshihara. Their collaborative efforts enhance the research environment at Knc Laboratories Co., Ltd., fostering a culture of innovation and scientific inquiry.

Conclusion

Hidekazu Imahori's contributions to the field of chemistry, particularly through his patent on vitamin D derivatives, highlight his innovative spirit and dedication to advancing scientific knowledge. His work continues to inspire future research in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…